Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magnesium levulinate is the magnesium salt of levulinic acid and is used as a mineral supplement to treat or prevent magnesium deficiency. It is classified as a nutraceutical and small molecule. Magnesium plays an essential role in numerous physiological processes, including enzyme function and energy metabolism. In some cases of congenital non-spherocytic haemolytic anaemia (CNSHA) with pyruvate kinase deficiency, administration of magnesium levulinate has been shown to increase pyruvate kinase activity by stimulating deficient ATPase activity in erythrocytes[1][3][4]. The compound dissociates to provide bioavailable magnesium ions after administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium levulinate.